0000000000433177

AUTHOR

Eduardo Moreno

showing 6 related works from this author

ChemInform Abstract: Synthesis and X-Ray Structure of Metalated Rhodium(II) Catalysts with a Chiral Phospholane.

2001

The reaction of Rh2(O2CR)4 (R = CH3, CF3) with the chiral phosphane (2S,5S)-2,5-dimethyl-1-phenylphospholane (PC*H), results in the formation of two diastereoisomers of Rh2(O2CCR)2(PC*)2, with (P) and (M) configuration. These can easily be isolated by chromatographic methods to obtain enantiomerically pure RhII compounds. Preliminary catalytic studies have shown that they induce moderate asymmetry in the cyclization of 5-aryl-1-diazo-2-pentanones and 1-diazo-5-hexen-2-one. X-ray analysis of the (M) diastereoisomer with formula Rh2(O2CCCH3)2(PC*)2 is reported. The crystallographic parameters are as follows: space group P21212 (orthorhombic) with a = 12.1347(11) A, b = 14.5870(13) A, c = 9.81…

CrystallographyChemistryX-rayDiastereomerchemistry.chemical_elementOrthorhombic crystal systemGeneral MedicineCatalysisRhodiumChemInform
researchProduct

Flower lose, a cell fitness marker, predicts COVID‐19 prognosis

2021

Abstract Risk stratification of COVID‐19 patients is essential for pandemic management. Changes in the cell fitness marker, hFwe‐Lose, can precede the host immune response to infection, potentially making such a biomarker an earlier triage tool. Here, we evaluate whether hFwe‐Lose gene expression can outperform conventional methods in predicting outcomes (e.g., death and hospitalization) in COVID‐19 patients. We performed a post‐mortem examination of infected lung tissue in deceased COVID‐19 patients to determine hFwe‐Lose’s biological role in acute lung injury. We then performed an observational study (n = 283) to evaluate whether hFwe‐Lose expression (in nasopharyngeal samples) could accu…

OncologyMedicine (General)medicine.medical_specialtyFlowersDiseaseQH426-470Lung injurySeverity of Illness Indexcell fitnessArticleR5-920COVID‐19Internal medicineSeverity of illnessGeneticsmedicineHumansPandemicsRetrospective StudiesReceiver operating characteristicSARS-CoV-2business.industryCOVID-19Retrospective cohort studyArticlesTriageMicrobiology Virology & Host Pathogen InteractionflowerROC CurvebiomarkerMolecular MedicineBiomarker (medicine)Observational studyprognosisbusinessBiomarkersEMBO Molecular Medicine
researchProduct

Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding

2007

The objective of this paper was to characterize the disposition phase of AM in rats, after different high doses and modalities of i.v. administration. Three fitting programs, WINNONLIN, ADAPT II and NONMEM were employed. The two-stage fitting methods led to different results, none of which can adequately explain amiodarone's behaviour, although a great amount of data per subject is available. The non-linear mixed effect modelling approach allows satisfactory estimation of population pharmacokinetic parameters, and their respective variability. The best model to define the AM pharmacokinetic profile is a two-compartment model, with saturable and dynamic plasma protein binding and linear tiss…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationAmiodaronePharmaceutical SciencePharmacologyAntiarrhythmic agentAmiodaroneModels BiologicalPharmacokineticsInternal medicineBlood plasmaAnimalsMedicineTissue DistributionDosingRats Wistareducationeducation.field_of_studyDose-Response Relationship Drugbusiness.industryBlood ProteinsBlood proteinsRatsNONMEMEndocrinologyArea Under CurveData Interpretation StatisticalInjections IntravenousbusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Diastereospecific control in the synthesis of enantiomerically pure bis-equatorial rhodium(II) catalysts by chiral phosphanes

2000

The reaction of Rh2(O2CR)4 [R = CH3, CF3] with the chiral phosphane (1S,2S,5R)-(2-hydroxy-5-isopropenyl-2-methylcyclohexyl)(diphenyl)phosphane, (+)PPh2(CH−R*−OH) or its enantiomer (1R,2R,5S)-(2-hydroxy-5-isopropenyl-2-methylcyclohexyl)(diphenyl)phosphane, (−)-PPh2(CH−R*−OH), results in the specific formation of the products (P)-Rh2(μ-O2CR)2(η1-O2CR)2{η2-(+)PPh2(CH−R*−OH)}2 [P(+)1, R = CH3; P(+)2 R = CF3] and (M)-Rh2(μ-O2CR)2(η1-O2CR)2{η2-(−)-PPh2(CH−R*−OH)}2 [M(−)1, R = CH3; M(−)2, R = CF3] in a high yield. Their synthesis, characterisation and catalytic behaviour in metal−carbenoid reactions are reported. X-ray analysis of P(+)2 and M(−)2 shows, in each case, a Rh24+ unit supported by two …

Inorganic ChemistryCoordination sphereDenticityChemistryStereochemistrychemistry.chemical_elementChelationTrigonal crystal systemEnantiomerChirality (chemistry)Medicinal chemistryRhodiumCatalysis
researchProduct

Synthesis and X-ray structure of metalated Rhodium(II) catalysts with a chiral phospholane

2001

The reaction of Rh2(O2CR)4 (R = CH3, CF3) with the chiral phosphane (2S,5S)-2,5-dimethyl-1-phenylphospholane (PC*H), results in the formation of two diastereoisomers of Rh2(O2CCR)2(PC*)2, with (P) and (M) configuration. These can easily be isolated by chromatographic methods to obtain enantiomerically pure RhII compounds. Preliminary catalytic studies have shown that they induce moderate asymmetry in the cyclization of 5-aryl-1-diazo-2-pentanones and 1-diazo-5-hexen-2-one. X-ray analysis of the (M) diastereoisomer with formula Rh2(O2CCCH3)2(PC*)2 is reported. The crystallographic parameters are as follows: space group P21212 (orthorhombic) with a = 12.1347(11) A, b = 14.5870(13) A, c = 9.81…

Inorganic ChemistryCrystallographychemistryStereochemistryDiastereomerX-raychemistry.chemical_elementOrthorhombic crystal systemChirality (chemistry)CatalysisRhodium
researchProduct

A Highly Regio-, Diastereo- and Enantioselective Intramolecular Cyclopropanation Reaction of a Racemic α-Diazo Ketone Catalyzed by Chiral ortho-Metal…

2003

Abstract A series of racemic dirhodium(II) compounds with two ortho-metalated aryl phosphine ligands in a head-to-tail arrangement Rh2(O2CR)2(pc)2 (pc=ortho-metalated aryl phosphine) (1a–k) were tested in the regio- and stereoselective cyclopropanation of racemic 1-diazo-6-methyl-3-(2-propenyl)-5-hepten-2-one 2, which possesses two different reactive CC double bonds for a five-membered-ring formation. The complexes Rh2(O2CCH3)2(pc)2 {pc=[(C6H4)P(C6H5)2], [(p-CH3C6H3)P(p-CH3C6H4)2], and [(C6H4)P(C6H5)(C6F5)]} (1a–d) successfully enhanced the cyclopropanation of trisubstituted versus monosubstituted CC bonds to give an 80:20 selectivity ratio. The reaction occurred with excellent diastereos…

chemistry.chemical_classificationKetoneDouble bondStereochemistryCyclopropanationArylOrganic ChemistryEnantioselective synthesisGeneral MedicineMedicinal chemistryCatalysisInorganic Chemistrychemistry.chemical_compoundchemistryStereoselectivityDiazoPhysical and Theoretical ChemistryPhosphineChemInform
researchProduct